JOMPAC

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

EndNote Style
Index
Original Article
Effects of smoking on the cardiopulmonary modulation during physical exercise in middle-aged non-obese healthy individuals
Aims: The aim of this study was to evaluate the overall effects of smoking and its duration on various cardiopulmonary modulation mechanisms during physical exercise in middle-aged non-obese healthy individuals.
Methods: Two hundred forty-three (142 smokers and 101 non-smokers), middle-aged, non-obese, healthy individuals were evaluated in this study. Parameters of pulmonary function including forced vital capacity (FVC), forced expiratory volume in the first second (FEV1) and FEV1/FVC ratio were evaluated using a spirometer and systolic pulmonary artery pressure (sPAP) were measured by echocardiography on rest and during various levels of exercise. A treadmill exercise test was used to assess heart rate recovery index (HRRI), the chronotropic index (CI) and the maximum rate of oxygen consumption during exercise (VO2max).
Results: Resting sPAP values were higher and FEV1, FVC and FEV1/FVC values were lower among smokers. As compared to resting values; FEV1 and FEV1/FVC ratio in smokers decreased significantly at peak exercise level (2.66±0.54 vs 2.35±0.49, p<0.01 and 81.57±8.21 vs 75.11±8.12, p<0.01 respectively). The HRRI values of all 1st, 2nd and 3rd minutes were significantly lower in the smoker group. Similar results were observed with CI and VO2max values (0.67±0.21 vs 0.76±0.19, p<0.01 and 34.91±4.63 vs 38.47±3.24, p<0.01 respectively). In addition, all mentioned parameters were significantly correlated with smoking duration.
Conclusion: Smoking is associated with a variety of adverse effects that may eventually reduce the exercise capacity of healthy individuals. These effects can manifest at early stages, and their severity correlates significantly with smoking duration.


1. World Health Organization. WHO report on the global tobaccoepidemic, 2011: warning about the dangers of tobacco. WorldHealth Organization, 2011. Available from:https://apps.who.int/iris/handle/10665/44616.
2. Powell R, Davidson D, Divers J, et al. Genetic ancestry and therelationship of cigarette smoking to lung function and per centemphysema in four race/ethnic groups: a cross-sectional study.Thorax. 2013;68(7):634-642.
3. Banks E, Joshy G, Korda RJ, et al. Tobacco smoking and risk of 36cardiovascular disease subtypes: fatal and non-fatal outcomes ina large prospective Australian study. BMC Med. 2019;17(1):128.
4. Shepherd JT. Circulatory response to exercise in health.Circulation. 1987;76(6 Pt 2):VI3-VI10.
5. Bove AA. Pulmonary aspects of exercise and sports. MethodistDebakey Cardiovasc J. 2016;12(2):93-97.
6. Papathanasiou G, Georgakopoulos D, Papageorgiou E, et al.Effects of smoking on heart rate at rest and during exercise,and on heart rate recovery, in young adults. Hellenic J Cardiol.2013;54(3):168-177.
7. Lauer MS, Pashkow FJ, Larson MG, Levy D. Association ofcigarette smoking with chronotropic incompetence and prognosisin the Framingham Heart Study. Circulation. 1997;96(3):897-903.
8. Rodr&iacute;guez-Fern&aacute;ndez A, Sanchez-Sanchez J, Ramirez-CampilloR, Nakamura FY, Rodr&iacute;guez-Marroyo JA, Villa-Vicente JG.Relationship between repeated sprint ability, aerobic capacity,intermittent endurance, and heart rate recovery in youth soccerplayers. J Strength Cond Res. 2019;33(12):3406-3413.
9. Smarz K, Tysarowski M, Zaborska B, et al. Chronotropicincompetence limits aerobic exercise capacity in patients takingbeta-blockers: real-life observation of consecutive patients.Healthcare (Basel). 2021;9(2):212.
10. Furlanetto KC, Mantoani LC, Bisca G, et al. Reduction of physicalactivity in daily life and its determinants in smokers withoutairflow obstruction. Respirology. 2014;19(3):369-375.
11. Helgerud J, H&oslash;ydal K, Wang E, et al. Aerobic high-intensityintervals improve VO2max more than moderate training. MedSci Sports Exerc. 2007;39(4):665-671.
12. Yuan YM, Luo L, Guo Z, et al. Activation of the renin-angiotensin-aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats. JRAAS2015;16(2):249-253.
13. Khalil MA. Smoking as a risk factor for intraoperative hypoxemiaduring one-lung ventilation. J Anesth. 2013;27(4):550-556.
14. Bossone E, Naeije R. Exercise-induced pulmonary hypertension.Heart Fail Clin. 2012;8(3):485-495.
15. Lin YH, Chen YC, Tseng YC, Tsai ST, Tseng YH. Physical activityand successful aging among middle-aged and older adults: asystematic review and meta-analysis of cohort studies. Aging.2020;12(9):7704-7716.
16. Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERSGuidelines for the diagnosis and treatment of pulmonaryhypertension. Eur Heart J. 2022;43(38):3618-3731.
17. Currie PJ, Seward JB, Chan KL, et al. Continuous wave Dopplerdetermination of right ventricular pressure: a simultaneousDoppler-catheterization study in 127 patients. J Am Coll Cardiol.1985;6(4):750-756.
18. Engeseth K, Hodnesdal C, Grundvold I, et al. Temporal reductionin chronotropic index predicts risk of cardiovascular deathamong healthy middle-aged men: a 28-year follow-up study. J AmHeart Assoc. 2016;5(12):e004555.
19. Romer LM, Polkey MI. Exercise-induced respiratory musclefatigue: implications for performance. J Appl Physiol (1985).2008;104(3):879-888.
20. W&uuml;st RC, Morse CI, de Haan A, Rittweger J, Jones DA, DegensH. Skeletal muscle properties and fatigue resistance in relation tosmoking history. Eur J Appl Physiol. 2008;104(1):103-110.
21. Tantisuwat A, Thaveeratitham P. Effects of smoking on chestexpansion, lung function, and respiratory muscle strength ofyouths. J Phys Ther Sci. 2014;26(2):167-170.
22. Twisk JW, Staal BJ, Brinkman MN, Kemper HC, van MechelenW. Tracking of lung function parameters and the longitudinalrelationship with lifestyle. Eur Respir J. 1998;12(3):627-634.
23. Gomes R, Lu&iacute;s F, Tavares A, Sousa N, Correia S, Reis M.Respiratory functional evaluation and pulmonary hyperinflationin asymptomatic smokers: Preliminary study. Rev Port Pneumol(2006). 2015;21(3):126-131.
24. Barutcu I, Esen AM, Kaya D, et al. Cigarette smoking andheart rate variability: dynamic influence of parasympatheticand sympathetic maneuvers. Ann Noninvasive Electrocardiol.2005;10(3):324-329.
25. Hellsten Y, Nyberg M. Cardiovascular adaptations to exercisetraining. Compr Physiol. 2015;6(1):1-32.
26. Astrand PO, Rodahl K, Dahl HA, Stromme SB. Textbook ofwork physiology. Physiological basis of Exercise. Champagne,IL:Human Kinetics; 2003. pp.134-176.
27. Myers J, Tan SY, Abella J, Aleti V, Froelicher VF. Comparison ofthe chronotropic response to exercise and heart rate recoveryin predicting cardiovascular mortality. Eur J Cardiovasc PrevRehabil. 2007;14(2):215-221.
28. Hawkins MN, Raven PB, Snell PG, Stray-Gundersen J, LevineBD. Maximal oxygen uptake as a parametric measure ofcardiorespiratory capacity. Med Sci Sports Exerc. 2007;39(1):103-107.
29. Keusch S, Hildenbrand FF, Bollmann T, et al. Tobacco smokeexposure in pulmonary arterial and thromboembolic pulmonaryhypertension. Respiration. 2014;88(1):38-45.
30. Vaillancourt M, Chia P, Sarji S, et al. Autonomic nervous systeminvolvement in pulmonary arterial hypertension. Respir Res.2017;18(1):201.
Volume 4, Issue 5, 2023
Page : 406-411
_Footer